Brief: Lytix Biopharma Q2 Loss For The Period Widens To NOK 31.4 Million

Lytix Biopharma AS

31/08/2023 07:26

Aug 31 (Reuters) - Lytix Biopharma AS  LYTIX.OL :
    * Q2 TOTAL OPERATING INCOME NOK 0.4 MILLION VERSUS NOK 11.7
MILLION YEAR AGO
    * Q2 LOSS FOR THE PERIOD NOK 31.4 MILLION VERSUS NOK 0.4
MILLION
YEAR AGO

Source text for Eikon:  ID:nObijyHPNa 
Further company coverage:  LYTIX.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))